1. Five healthy male subjects were studied by continuous infusion of L-[Ix-' 5N]lysine over 20-30 h with timed blood and urine samples, and two or three percutaneous needle biopsies of vastus lateralis muscle.
Introduction
During the last 25 years several authors have calculated total body protein turnover rates using variations of the original methods of Sprinson & Rittenberg (1949) and Wu & Snyderman (1950) . Calculations of protein turnover rates in these early studies were based on the curve of ISN excretion in urine over a 2 day period after ingestion of a single dose of a 15N-labelled amino acid. Later methods have been described by San Pietro & Rittenberg (1953) , and Olesen, Heilskov & Schernheyder (1954) . The former investigators based their calculation of protein turnover on the interval between pulse label 15N administration and the appearance of maximum 15N enrichment in urinary urea, whereas the latter group measured the urinary excretion of 15N over a 15 day period after a single administration of [ 5N] glycine. Calculation of protein synthesis was performed by multicomponent analysis of the excretion curves. The inherent assumptians involved in these studies have been critically reviewed by Wu, Sendroy & Bishop (1959) and Tschudy, Bacchus, Weissman, Watkin, Eubanks &White (1959) .
The constant-infusion technique resulting in a plasma plateau of infused label has been used recently to study protein synthetic rates in man, both radioactive (Waterlow, 1967; James, Garlick & Sender, 1974) and stable isotopes (Picou & Taylor-Roberts, 1969 ; Young, Steffee, Pencharz, Winterer & Scrimshaw, 1975) being used. The use of l4C-1abelled amino acids to calculate protein synthetic rate limits the age group available for study, and the permissible radioactivity infused (50 pCi) precludes measurement of specific tissue protein synthetic rates.
We have therefore used continuous infusion of a stable isotope to measure plateau labelling in plasma, and thus to calculate whole body flux and protein synthetic rates in man. By the relatively non-traumatic technique of percutaneous needle biopsy of the vastus lateralis muscle, serial biopsies were taken, with extraction, purification and measurement of isotope labelling in both sarcoplasmic and myofibrillar protein fractions. The fractional sarcoplasmic and myofibrillar synthetic rates were calculated and, from an estimate of muscle mass based on creatinine excretion, total body synthetic rates were obtained.
[ 5N]Lysine, an essential amino acid which undergoes irreversible oxidative transamination (Weissman & Schsenheimer, 1941 ) with few degradative pathways (Fellows, 1973) , was chosen for this study because it presented plateau conditions within the plasma in a reasonable time-period (Waterlow, 1967) , was readily resolved by column chromatography and gave detectable enrichment in purified muscle protein fractions.
Patients and methods

Clinical protocol
The five experimental subjects were healthy male volunteers from the scientific staff. These studies were approved by the Ethical Committee of Northwick Park Hospital and the Clinical Research Centre. The purpose of the investigation was explained to each individual and their full consent was obtained. The results of their total body potassium measured in a multicrystal whole-body counter to an accuracy of 53.3% are shown in Table 1 . Their resting O2 uptake was also assessed by indirect calorimetry in a ventilated hood. A standardized creatine-free diet was given for 5 days before the infusion, permitting subsequent calculation of muscle mass from creatinine excretion. The diet contained 40 g of protein/m2 and 5 mJ/m2 body surface area.
Intravenous infusions were commenced at 08.30 hours and continued at a constant rate with the use of an Ivac drip counter, previously shown to give a rate of delivery of 40 ml/h with an hourly variation of < k1.5%. The infusion solution consisted of Aminoplex 14 (a mixture of essential and nonessential L-form amino acids equivalent to 13.4 g of utilizable N/1) and the [15N]lysine. Carbohydrate drinks were given at 2 h intervals throughout the infusion to supply 5 MJ day-' m-2. Infusions were continued for 21-30 h at a constant rate in all subjects except subject no. 1, who received an initial pulse injection. Timed urine samples were taken during the infusion together with five to nine blood samples (40 ml). Percutaneous needle biopsies of vastus lateralis muscle (Edwards, 1971) were performed on subject no. 1 at 0 and 20 h, on subjects no. 2 and no. 4 at 0, 14 and 30 h, and on subjects no. 3 and no. 5 at 14 and 30 h. 
Chemical methods
Plasma free lysine. Plasma proteins were precipitated with 5 vol. of 1 % picric acid and centrifuged (2000 g for 15 min at 4°C). The supernatant was passed down a column (2 cm x 2 cm) of an anionic resin (Bio-Rad AG 2; X8) to remove excess of picrate, and the effluent was rotary-evaporated to dryness. The residue was taken up in 1-15 ml of HCI (100 mmol/l) and free lysine was resolved on the short basic column of a Technicon TSM amino acid analyser. Lysine was recovered by fraction collection after the retention time had been determined with ~- [4,5-~H] lysine. An aliquot (0.1 ml) of the mixture was used to determine absolute plasma lysine concentrations, L-canavanine being used as an internal standard.
Serum albumin. Serum albumin samples prepared by the method of Korner & Debro (1956) were dialysed against repeated changes of distilled water for 6 days. Purity of the albumin was con6rmed by polyacrylamide disc electrophoresis. Urinary urea. Urea samples for 5N analysis were prepared as the xanthydrol derivative according to the method of Bianchi & Mariani (1969) .
Total urinary nitrogen. An aliquot of urine from each timed collection, containing approximately 1 mg of nitrogen, was digested and measured by Kjeldahl analysis with selenium dioxide as catalyst.
Sarcoplasmic protein and myojibrillar protein lysine
Sarcoplasmic and myofibrillar protein was extracted and purified by the method of Millward (1970) , and finally dialysed for 6 days against repeated changes of distilled water. The isotopic enrichment was determined in the total nitrogen of the sarcoplasmic protein without further treatment as separation of free lysine from this fraction would have yielded insufficient total nitrogen for reliable mass spectrometric analysis. The myofibrillar protein was hydrolysed with 1 ml of HCl (6 mol/l) in sealed tubes at 110°C for 22 h. The hydrolysate was evaporated to dryness in a rotary evaporator and washed three times with distilled water to eliminate HCl residue. Lysine was separated from the amino acid mixture in a similar manner to that outlined for plasma free lysine and used for the determination of 5N content.
Sample preparation for isotopic analysis
The ammonia formed from Kjeldahl digestion of plasma and myofibrillar free lysine, sarcoplasmic protein, plasma albumin and urinary urea was steam-distilled into 0.3 ml of dilute sulphuric acid (100 mmol/l). The pH of the distillate was adjusted to 3.0 with sodium hydroxide and Bromophenol Blue and the ammonium sulphate solution evaporated to dryness for isotopic analysis. The time-course for complete Kjeldahl digestion was checked to ensure that complete conversion into ammonia had occurred of the labelled a-and unlabelled €-nitrogen atoms. Nitrogen was liberated from the ammonium sulphate sample by the action of lithium hypobromite. The hypobromite reaction was performed in special miniature glass vessels (5 ml volume) at an initial vacuum of 1-3 x 10-3 Pa. The 15N enrichment was expressed as atom % excess compared with a comparable sample obtained from each subject before the infusion.
Mass spectrometer
The mass spectrometer was an AEI MS20, viscous inlet, double-focusing machine. A rhenium filament was used in preference to tungsten to minimize the formation of carbon monoxide within the source. Modifications to the inlet system permitted the analysis of small nitrogen samples (25-100 pg), which were introduced into the source by means of a manual toeppler pump. The capillary leaks were crimped to handle small samples. The spectrometer was fitted with an all-glass solenoidoperated McKinney change-over valve, facilitating alternate measurement of standard and sample isotopic ratios.
Measurement and calculation of isotope labelling
The calculations used in this investigation depend on measurements of low levels of enrichment in small samples of protein. If lysine labelled with 15N is used as a tracer it is necessary to measure how much more 15N is present in the protein sample than would have been the case if no tracer lysine had been given. It cannot be assumed that the abundance of 15N in all tissues of a subject who has not received any artificially enriched 5N-labelled compound have the same 15N enrichment. We have found that there are small differences in the initial enrichment of 5N in the different nitrogenous fractions obtained from any given normal subject, presumably due either to dietary variations in 15N intake, or to isotope fractionation during metabolic processes in the body (Gaebler, Vitti & Vukmirovich, 1966) . It is therefore necessary, if accurate measurements are to be made, to determine the 15N enrichment in the nitrogenous fraction to be studied both before and after the labelled amino acid is given.
The reproducibility of the measurements in the mass spectrometer on samples of about 25-100 pg of nitrogen was tested to assess the long-term stability of the machine, and also to check on any isotope fractionation during the preparation of samples of nitrogen from protein. A stock of enriched ammonium sulphate and of human albumin was prepared, and on thirteen occasions over a period of 14 months nitrogen samples were made from these starting materials for replicate isotope analysis. The standard deviation on the enrichment of these samples was 0.21% for the ammonium chloride and 0.20% for the albumin. The range of variation on repeated measurements of replicate samples prepared at the same time was always less than 0.02% enrichment, which in terms of atoms % excess is equivalent to an error of 0.000073. The values for atoms % excess in Table 3 of this paper are given to four decimal places, since the value for the fourth decimal place is still within the reproducibility of the measurement. Fig. 1 demonstrates the increase in labelling of plasma free lysine during infusion in the five subjects studied. Subject no. 1 received an initial pulse label of [ 5N]lysine. Subjects nos. 2-5 achieved plateau values within 14-16 h, after which there was no appreciable increase in the degree of labelling (2-3% variation). The mean value for plasma [' 5N]lysine enrichment at plateau was calculated from the values obtained from 18 h to the end of the infusion. Calculated values for lysine flux demonstrated considerable variability (Table 2) . Total body protein turnover was calculated from these values ( Table 2 ) and related to body weight, lean body mass and oxygen uptake with no reduction in the degree of variability. Fig. 2 demonstrates the increase in the extent of labelling of urinary urea during infusion. Plateau labelling was not achieved in up to 30 h infusion. The excretion of label in total urinary nitrogen accounted for 3-3.5% of the infused [15N]lysine in all subjects (Table 2) , of which 80435% was in urea. The increase in the isotopic labelling of blood urea during the infusion approximated to that of urinary urea. Urine from subject no. 1 was used to demonstrate that less than 0.05% of the infused 5N was excreted as urinary ammonia. Table 3 demonstrates the increase in labelling in sarcoplasmic, myofibrillar and intravascular albumin fractions after specified time-intervals, together with their calculated fractional protein synthetic rates during plasma plateau conditions. Fig. 3 shows the increase in labelling of intravascular albumin in four subjects during the infusion of ['5N]lysine. The level of 15N enrichment in urea, plasma albumin, myofibrillar and sarcoplasmic protein before the infusion was started showed variations both between subjects and within subjects. The magnitude of these variations is shown in Table 3 , where the atom % excess of sarcoplasmic protein and myofibrillar lysine nitrogen in subjects nos. 1, 2 and 4 at zero time differ slightly between subjects and from the nitrogen reference gas. Table  3 demonstrates the markedly lower fractional synthetic rate of the muscle proteins compared with albumin, and that the myofibrillar protein synthetic rate was lower than that of sarcoplasmic protein in all subjects. The ratio of sarcoplasmic to myofibrillar fractional synthetic rate showed reasonable agreement except for subject no. 2, where presumably contamination with blood had occurred. For the calculation of sarcoplasmic protein synthetic rate in subject no. 2, a mean value of this ratio in the remaining four subjects was applied. There was a general relationship between the plasma lysine flux and the myofibrillar fractional synthetic rate, shown by subject no. 1 with a high flux and the highest synthetic rate, and by subject no. 5, who had both the lowest flux and myofibrillar synthetic rate (Tables 2 and 3 ).
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Total muscle protein synthetic rate Table 4 contains the calculated values for myofibrillar and sarcoplasmic protein synthesis and the contribution of these fractions to total body protein turnover derived from the plasma lysine flux. The excretion of creatinine was measured over the first 24 h of the infusion. Total muscle mass was calculated with l g of creatinine taken as equivalent to 20.0 kg of muscle (Graystone, 1968) . Protein was assumed to constitute 20% of muscle mass, and was subdivided as myofibrillar protein (65 %), sarcoplasmic protein (25%) and stromal protein (10%). Muscle was calculated to account for 53.2% (range 39.5-62.1 %) of total protein turnover in man.
Discussion
The rate of protein synthesis in vitro in hepatic subcellular systems is approximately 100 times less rapid than in the liver in vivo (Henshaw, Hirsch, Morton & Hiatt, 1971 ) and gives no indication of the rate of total body protein turnover, a measure of the summated effect of protein synthesis in all the tissues of the body. Since muscle contains 45% of the total protein mass of the body, alterations in the rate of protein synthesis in this heterogeneous pool during dietary variation and in disease, would be expected markedly to affect the rate of total body protein turnover. The present study was undertaken to establish the variation in both total body and muscle fractional protein synthetic rates in healthy volunteers. Previous estimates of the rate of total body protein synthesis based on the 15N enrichment of urinary urea, over a variable time-course, have produced paradoxical results with an apparent increase in synthetic rates in malnourished children (Picou & Taylor-Roberts, 1969) , and normal adults on a low-protein diet (Steffee, Pencharz, Goldsmith, Anderson & Young, 1973) . However, continuous infusion of 14C-labelled amino acids into rats fed on protein-depleted diets (Waterlow & Stephen, 1968) and into calorie-restricted obese patients (Sender, James & Garlick, 1974; James, Sender, Garlick & Waterlow, 1974) produced the expected fall in tissue and whole-body protein synthetic rates. This apparent anomaly may be explained in terms of the 15N enrichment in urinary urea being a reflection more of hepatic than of whole-body nitrogen turnover. During conditions of dietary restriction of protein, hepatic protein breakdown continues with a relative segregation of the hepatic amino acid precursor nitrogen pool from the plasma pool of labelled amino acids, giving rise to a reduced enrichment of urinary urea synthesized in the liver, and thus increase in the calculated total body protein synthetic rate. Evidence to support a relative segregation of the hepatic nitrogen pool in rats fed on a protein-free diet with intravenous infusion of [U-'4C]tyrosine was obtained by P. J. Garlick, D. J. Millward & W. P. T. James (unpublished work), with the finding of a reduction in the labelling of the hepatic pool of free tyrosine. Evidence was also obtained which suggested that the control of hepatic protein synthesis and breakdown was different from that of other tissues such as muscle, emphasizing the difficulties in using 15N enrichment in urinary urea as a reflection of total body protein synthesis.
The techniques of both constant infusion and pulse injection of label share the common premise that there is a homogeneous metabolic nitrogen pool of which plasma constitutes a part. A variety of animal experiments have demonstrated that this is an over-simplification, since constantly infused rats showed a hepatic intracellular equilibrium time which was much faster than that of muscle (Gan & Jeffay, 1967) . The present study in man supports the findings of Gan & Jeffay (1967) for rats, since protein synthetic rate during the first 14 h of infusion for plasma albumin was 70%, and myofibrillar protein 30% of the final value calculated during plasma plateau conditions. This provides indirect support for the concept of a heterogeneous nitrogen pool, by suggesting that the hepatic precursor amino acid pool for protein synthesis reaches equilibrium with respect to plasma enrichment before the muscle pool. The absolute values for albumin synthesis are, of course, much higher than those obtained for the catabolic rate of albumin labelled with 1311 (Schultze & Heremans, 1966) . In this study the incorporation of label into intravascular albumin was measured over a relatively short time, so the fractional synthetic rate is that of a small and undefined portion of the whole-body albumin pool. Thus the apparent fractional turnover rate is more than twice the true whole-body albumin turnover rate.
Recently there has been controversy surrounding the free amino acid precursor pool for protein synthesis, with evidence presented for amino acids being taken up directly from the extracellular space for synthesis (Hider, Fern & London, 1971) , and the more recent demonstration that the specific activity of the total intracellular free amino acid pool is a better basis for calculation of specific tissue protein synthesis (Fern & Garlick, 1973) . Investigations in man preclude prolonged infusions, with repeated tissue sampling sufficient to establish accurately, with present techniques, the relationship between the plasma and the intracellular pool specific activity for any given amino acid. Therefore, in the present investigation plasma plateau enrichment of [15N]lysine was used to calculate total body and muscle protein synthetic rates.
Plateau labelling was achieved with continuous infusion of [ 5N]lysine at between 14 and 16 h, which was in good agreement with the results of Waterlow (1967) with [14C]lysine. The results for total body protein synthesis based on plasma plateau labelling of free lysine were similar to those described by previous authors using different methods with stable isotopes, and a similar method with radio-active isotopes (Waterlow, 1969; James et al., 1974) . The finding of 3-35 % of the infused dose of [I 5N]-lysine recovered during the infusion as total urinary nitrogen suggests that there was minimal transfer of 15N to other amino acids and insignificant contamination from the D-isomer, which was also reflected in the constancy of the plateau concentrations achieved.
In the present study L-lysine was used because of its availability, its high free concentration in plasma and thus the relatively small volume of plasma (15 ml) required for I5N analysis of free lysine, and its relatively high percentage contribution to the total nitrogen of mixed muscle proteins (Furst & Jonsson, 1971) . Muscle biopsies were obtained at 14 and 30 h, when plasma concentrations of [15N]lysine had reached a plateau. The delay in equilibrium between plasma and intracellular specific activity revealed in animal experiments, suggests that the results obtained for muscle protein synthetic rates are an underestimate. The results for sarcoplasmic protein synthetic rate show greater variation than that for the myofibrillar protein, reflecting the heterogeneity of the protein pool and variable blood contamination. In all subjects the rate of sarcoplasmic protein synthesis was more than double the myofibrillar protein synthesis, suggesting a faster turnover rate in muscle of enzymatic proteins involved in intermediary metabolism as compared with structural proteins.
These figures should provide a useful basis for comparison with synthetic rates in diseased states under strictly comparable conditions. Recent investigations in animals (Buttery, Beckerton, Mitchell, Davies & Annison, 1975) indicate the fractional protein synthetic rates for different skeletal muscles are approximately equal, although cardiac muscle was twice that for voluntary striated muscle. If similar considerations apply to human muscle fractional protein synthetic rates then the turnover time of whole-body myofibrillar protein is approximately 70 days, and sarcoplasmic protein 25 days. Total muscle protein synthesis was calculated t o account for 53% of total body protein turnover, establishing the quantitative importance of muscle protein synthesis in protein metabolism of the whole body.
